Related Experiment Videos
Sideroblastic anaemia associated with lincomycin therapy.
Postgraduate Medical Journal
|December 1, 1983
Summary
Lincomycin therapy can cause sideroblastic anemia, a reversible condition. Prompt diagnosis and treatment with pyridoxine are crucial for recovery.
Area of Science:
- Hematology
- Pharmacology
- Toxicology
Background:
- Lincomycin is an antibiotic used for bacterial infections.
- Sideroblastic anemia is a group of disorders characterized by anemia and the presence of ring sideroblasts in the bone marrow.
Observation:
- A 58-year-old woman developed sideroblastic anemia during lincomycin therapy.
- The patient also experienced pseudomembranous enterocolitis, a known side effect of lincomycin.
Findings:
- Sideroblastic anemia resolved completely after discontinuing lincomycin.
- Pyridoxine (vitamin B6) administration was associated with the reversal of anemia.
Implications:
- This case highlights a potential drug-induced sideroblastic anemia secondary to lincomycin.
- Early recognition and pyridoxine supplementation may be beneficial in managing this adverse effect.